Home
 /
Papers
 /
Cancer Biology
 /
Lineage-determining transcription factors constrain cohesin to drive multi-enhancer oncogene regulation
Preprint
Open access
V1
Top 1% · Validated by QED

Lineage-determining transcription factors constrain cohesin to drive multi-enhancer oncogene regulation

Yeqiao Zhou, Atishay Jay, Noah Burget +7 more
October 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.10.10.681717
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Cancer Biology this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

By demonstrating at single-allele resolution that lineage-determining transcription factors centralize enhancers and promoters by blocking cohesin extrusion, this work overturns pairwise looping models and establishes a geometric logic for multi-enhancer oncogene control.

QED claims analysis

Summary

Lineage-determining transcription factors EBF1 and TCF1 constrain cohesin-mediated loop extrusion to position distal enhancers and promoters at the geometric centers of individual chromatin fibers, thereby enabling multi-enhancer interactions that drive cell-type-specific oncogene expression in B-cell lymphoma and T-cell leukemia.

See full analysis
Main Claim 1 –

EBF1 Binds Distal Enhancers and Is Essential for MCL

Supporting evidence

  • EBF1 Acts Without Rapid Changes in Accessibility, TADs, Compartments
Main Claim 2 –

EBF1 Preferentially Regulates Genes in Gene-Sparse Enhancer Hubs

Main Claim 3 –

EBF1 Shifts Frequencies of Pre-Existing Allelic Topological Conformations

Main Claim 4 –

Enhancer–Promoter Interactions Occur at Allelic Geometric Centers

Supporting evidence

  • Gene Activation Alone Does Not Drive Central Regulatory Positioning
  • EBF1-Activated Distal Enhancers Drive Central Enhancer–Promoter Positioning
  • Central Positioning Mechanism Extends Beyond EBF1 to TCF1

Abstract

Multiple enhancers, often located across vast genomic distances, regulate key genes. However, how chromatin topology organization at individual alleles enables cell-type-restricted multi-enhancer gene regulation remains unclear. Using acute protein degradation and time-course population-average chromatin conformation capture in lymphoma, we found that the B-cell- lineage-determining transcription factor EBF1 preferentially positions multiple enhancers at loci containing sparsely distributed genes essential for B-cell identity and oncogenesis. Our time-resolved sub-diffraction optical chromatin architecture tracing of >100,000 alleles in individual lymphoma cells further revealed diverse topological conformations facilitating multi-enhancer interactions. Mechanistically, we found that positioning of enhancers at allelic topological centers is required for their interactions with target promoters, with EBF1 serving as a barrier to the loop-extruding cohesin on enhancers. These findings, which we demonstrate their generalizability to the T-cell-lineage-determining transcription factor TCF1 in T-cell leukemia, suggest that lineage-determining transcription factors radially position enhancers and promoters to enable multi-enhancer regulation of key oncogenes.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?